Andrew Aromando - 11 Dec 2023 Form 4 Insider Report for Ambrx Biopharma, Inc.

Reporting relationship: Chief Operating Officer
Issuer ticker: N/A
Reported as of: 11 Dec 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Dec 2023, 17:19:44 UTC
Prior SEC filing: 07 Jul 2023
Next SEC filing: 07 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Sonja Nelson, Attorney-in-Fact for Andrew Aromando

Key filing fact

Andrew Aromando filed Form 4 for Ambrx Biopharma, Inc. on 11 Dec 2023.

Key facts

This page summarizes Andrew Aromando's Form 4 filing for Ambrx Biopharma, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Dec 2023, 17:19.

Change

Previous filing in this sequence was filed on 07 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMAM transaction

Common Stock

Award

Transaction value: $0
Shares: +100,000
Change %: +1080%
Price: $0.000000
Shares after: 109,263
Date: 11 Dec 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents Restricted Stock Units ("RSUs") payable in common stock of the Issuer granted to the Reporting Person on December 11, 2023 (the "Grant Date"). These RSUs were granted in connection with the completion of the year-end review process and will be issued pursuant to the Company's Amended and Restated 2021 Equity Incentive Plan.

Footnote F2

The RSUs will vest over thirty-six (36) months as follows: (i) one-sixth (1/6) of the RSUs will vest on the six (6)-month anniversary of the Grant Date, and (ii) one-twelfth (1/12) of the RSUs will vest on a quarterly basis thereafter.